Clinical Trial Update: VR-Based Optokinetic Stimulation in Multiple Sclerosis [NA]

View source ↗

Summary

A clinical trial investigating VR-based optokinetic stimulation for Multiple Sclerosis is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• VR-Based Optokinetic Stimulation

Snippet

Sponsor: Avrasya University | Conditions: Multiple Sclerosis | NA | Status: NOT_YET_RECRUITING